Astra Industrial Group · TADAWUL:1212
Astra Industrial — H1 2026 Earnings Presentation
28 slides from Astra Industrial's earnings presentation, 2026
Slide 1: Astra Industrial Group Investor Presentation H1 2026
Astra Industrial Group Investor Presentation H1 2026 Saudi Exchange: 1212 | Tadawul Riyadh, Kingdom of Saudi Arabia | Confidential
Slide 2: Contents
Contents Corporate Data 01 Business Overview & Key Highlights pg. 03 Head Office Riyadh, Saudi Arabia 02 Tabuk Pharmaceuticals pg. 05 Group Listed 2008 03 Specialty Chemicals pg. 11 Paid-in Capital SAR 800,000,000 Total Shares 80,000,000 04 International Building Systems Factory pg. 17 Ticker Code 1
Slide 3: Who We Are
Who We Are Astra Industrial Group — Overview Astra Industrial Group is a Saudi industrial investment group headquartered in Riyadh with a strong industrial footprint across KSA, the Middle East, North Africa, India and Global Presence Germany. Listed on the Saudi Stock Exchange (Tadawul) since 2008,
Slide 4: Key Highlights: Financial Summary H1 2026
Key Highlights Financial Summary — H1 2026 3,900+ 15+ 40 Employees Manufacturing Facilities Global Markets +1% +10% +5% SAR 1,567 M SAR 769 M SAR 365 M Revenues Gross Profit Net Profit +10% +4% +23% SAR 4,874 M SAR 3,080 M SAR 1,793 M Total Assets Total Equity Total Liabilities * Revenues, gross pro
Slide 5: Tabuk Pharmaceuticals
Tabuk Pharmaceuticals Largest privately-owned pharmaceutical company in Saudi Arabia
Slide 6: Tabuk Pharmaceuticals Overview
Tabuk Pharmaceuticals Overview Overview Market Mission & Scale Regional Reach Leadership Established in 1994, headquartered We are proudly among the top Investing in differentiated technologies to deliver high-quality, Our strong market presence in Riyadh, our plants produce over 2 leading pharmaceu
Slide 7: Tabuk Pharmaceuticals Financial Snapshot
Tabuk Pharmaceuticals — Financial Snapshot +12% +19% +6pp SAR 871 M SAR 1,650 M 56% Revenues (H1 2026) Total Assets Business Share (H1 2026) Manufacturing Footprint Tabuk City, KSA Dammam, KSA Algeria Sudan Sterile & Non-sterile manufacturing General injectables facilities Currently shutdown. Holdin
Slide 8: Tabuk Pharmaceuticals Key Achievements
Tabuk Pharmaceuticals — Key Achievements Commercial & Market Manufacturing Excellence Growth • Maintaining leadership in major therapeutic areas and expanding • 4 state-of-the-art manufacturing sites across KSA, Algeria & Sudan in new areas producing sterile and non-sterile cephalosporin & non- • Ac
Slide 9: Key Market Developments
Key Market Developments KSA Therapeutic Area Performance — H1 2026 Therapeutic Area Market Share Rank Key Insights Cardiovascular System 21% 1st Maintaining leadership in the KSA private market for key therapy areas (CVS, Genito Urology, Musculoskeletal & CNS) Musculoskeletal 12% 1st Diversifying th
Slide 10: Recent Licensing Deals
Recent Licensing Deals Tabuk Pharmaceuticals — Q2 2026 Partnerships Partner Molecule / Brand Therapeutic Area Strategic Rationale Carmellose Ophthalmology Expand Tabuk’s Ophthalmology Portfolio Ciclosporin Oncology Expand Tabuk’s Oncology Portfolio Loxoprofen Consumer Healthcare Introduce a differen
Slide 11: Specialty Chemicals
Specialty Chemicals Agrochemicals · Fertilizers · Masterbatch & Additives
Slide 12: Specialty Chemicals Financial Snapshot
Specialty Chemicals — Financial Snapshot -4% 0% -2pp SAR 506 M SAR 917 M 32% Revenues (H1 2026) Total Assets Business Share (H1 2026) Manufacturing Footprint AstraChem Astra Polymers • 2 in KSA (Dammam & Rabigh) • 2 plants in Dammam, KSA • 2 in UAE (Jafza & Kezad) • 1 in Turkey • 1 in Turkey • 1 in
Slide 13: AstraChem Overview
AstraChem — Overview Company Overview End-to-End Solutions Founded in 1988, AstraChem is a leading Operating as a vertically integrated producer, we regional manufacturer dedicated to meeting the support farmers and businesses from product growing demand for high-quality compounded development and f
Slide 14: AstraChem Key Highlights H1 2026
AstraChem — Key Highlights H1 2026 Highlights Challenges Strategy Shift Logistics Continued shipping disruptions due to geopolitical instability, supply Focusing on B2B expansion in strategic markets while exiting B2C chain bottlenecks, port congestion, and volatile freight rates, increasing high-ri
Slide 15: Astra Polymers Overview
Astra Polymers — Overview Company Overview Polymer Manufacturing Expertise Certified Excellence Established in 1993, Astra Polymers has grown into a We are a market leader in producing advanced Our commitment to safety, quality, and premier manufacturer of high-quality masterbatch and black, white,
Slide 16: Astra Polymers H1 2026 Results
Astra Polymers – H1 2026 Results Highlights Challenges Sales & volume growth Raw material supply Higher sales volume and revenue YoY across Petrochem and non- Longer routes and tighter availability, with limited local market supply Petrochem businesses. of polymer for us and our customers. Supply co
Slide 17: International Building Systems Factory
International Building Systems Factory Class-A EPC contractor for commercial & industrial steel fabrication
Slide 18: IBSF Financial Snapshot
IBSF — Financial Snapshot -23% -8% -4pp SAR 190 M SAR 350 M 12% Revenues (H1 2026) Total Assets Business Share (H1 2026) Expert Technical Workforce Advanced Custom Fabrication The Company’s expert team includes qualified engineers, certified The Company operates four (4) advanced steel fabrication p
Slide 19: IBSF Key Highlights H1 2026
IBSF — Key Highlights H1 2026 Highlights Challenges Project Selection Raw material prices volatility Strategic project selection by only taking on high margin projects and Volatile raw material prices and supply chain disruptions affecting cost therefore driving gross margin improvement. management.
Slide 20: IBSF Clients
IBSF — Clients Astra Industrial Group | Investor Presentation H1 2026 | Confidential 1212 | Tadawul
Slide 21: Financial Performance Highlights
Financial Performance Highlights
Slide 22: Performance Highlights
Performance Highlights Resilient profitability with margin expansion Astra Industrial Group delivered solid financial performance in H1 2026, demonstrating resilience and operational excellence across its diversified portfolio despite challenging market conditions. Revenue Net profit H1 2026 Q2 2026
Slide 23: Revenue & Segment Contribution
Revenue & Segment Contribution Segment Performance — H1 2026 vs. H1 2025 871 Revenue Mix H1 2026 Revenue Mix H1 2025 775 12% 16% 527 506 50% 32% 56% 34% 247 190 Pharma Chemicals Steel Pharma Chemicals Steel Pharma Chemicals Steel H1 2025 H1 2026 Pharma +12% Growth led by public tender (NUPCO) delive
Slide 24: Profitability by Sector
Profitability by Sector EBITDA Performance — H1 2026 vs H1 2025 Pharma +10% 305 278 Higher gross profit (+SAR 50M) on tender-led growth lifted EBITDA YoY. Revenue +12% to SAR 871M and finance costs SAR 3.6M lower. EBITDA margin 35% (H1 25: 36%). Chemicals +24% Margin recovery lifted EBITDA despite s
Slide 25: Consolidated Income Statement
Consolidated Income Statement Our financial performance demonstrates strong operational efficiency and improved margins year-over-year. SAR M H1 2026 H1 2025 Q2 2026 Q2 2025 Gross Profit Growth Revenue 1,567 1,549 776 715 GP up SAR 70M YoY (+10%), driven by Pharma (+SAR 50M), Chemicals (+SAR 12M) an
Slide 26: Balance Sheet
Balance Sheet As at 30 June 2026 vs. 31 December 2025 SAR M Jun 2026 Dec 2025 SAR M Jun 2026 Dec 2025 Property, Plant & Equipment 945 905 Share Capital 800 800 Intangible Assets 56 55 Retained Earnings 2,257 2,169 Goodwill 31 32 FX Translation Reserve (8) (7) Investment at Amortized Cost (Sukuks) 25
Slide 27: Working Capital & Cash Conversion Cycle
Working Capital & Cash Conversion Cycle 184 DSO DIO DPO 161 165 160 Working Capital 146 140 134 122 Net working capital SAR 835M on 30 June 2026 vs SAR 774M on 118 120 31 December 2025. Current ratio 1.54x vs 1.64x, due to loan increase in 2026 H1. 60 62 Cash Conversion Cycle 57 53 50 CCC of 244 day
Slide 28: Thank You
Thank You Astra Industrial Group Saudi Industrial Investment Group | Tadawul: 1212 P.O. Box 1560, Riyadh 11441 | Tel: +966 11 475 2002 | ir@aig.sa | www.aig.sa This presentation has been prepared by Astra Industrial Group for informational purposes only and is strictly confidential.
Astra Industrial Group — H1 2026 Earnings Presentation on 6ix